In the last trading session, 1.54 million shares of the Evolent Health Inc (NYSE:EVH) were traded, and its beta was 1.48. Most recently the company’s share price was $9.86, and it changed around -$0.08 or -0.80% from the last close, which brings the market valuation of the company to $1.15B. EVH currently trades at a discount to its 52-week high of $35.00, offering almost -254.97% off that amount. The share price’s 52-week low was $9.56, which indicates that the current value has risen by an impressive 3.04% since then. We note from Evolent Health Inc’s average daily trading volume that its 10-day average is 1.73 million shares, with the 3-month average coming to 2.51 million.
Evolent Health Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.13. If we narrow it down even further, the data shows that 0 out of 16 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 1 recommended EVH as a Hold, whereas 10 deemed it a Buy, and 0 rated it as Underweight. Evolent Health Inc is expected to report earnings per share of 0.01 for the current quarter.
Evolent Health Inc (NYSE:EVH) trade information
Instantly EVH has showed a red trend with a performance of -0.80% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 10.54 on recent trading dayincreased the stock’s daily price by 6.45%. The company’s shares are currently down -12.36% year-to-date, but still down -3.80% over the last five days. On the other hand, Evolent Health Inc (NYSE:EVH) is -21.37% down in the 30-day period. We can see from the shorts that 11.16 million shares have been sold at a short interest cover period of 4.95 day(s).
The consensus price target as assigned by Wall Street analysts is $19, which translates to bulls needing to increase their stock price by 48.11% from its current value. Analyst projections state that EVH is forecast to be at a low of $14 and a high of $38.
Evolent Health Inc (EVH) estimates and forecasts
The year-over-year growth rate is expected to be 30.33%, up from the previous year.
Consensus estimates provided by 14 financial analysts predict the company will bring in an average of 651.01M in revenue for the current quarter. 11 analysts expect Evolent Health Inc to make 599.8M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 556.05M and 639.65M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 17.08%. Forecasts for the next quarter put sales growth at -6.23%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -13.43%. Evolent Health Inc earnings are expected to increase by -18.60% in 2025, but the outlook is positive 0.83% per year for the next five years.
Evolent Health Inc (NYSE:EVH)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 2.26% of Evolent Health Inc shares, and 114.82% of them are in the hands of institutional investors. The stock currently has a share float of 117.48%. Evolent Health Inc stock is held by 364.0 institutions, with WELLINGTON MANAGEMENT GROUP LLP being the largest institutional investor. By 2024-06-30, it held 9.785% of the shares, which is about 11.17 million shares worth $213.55 million.
VANGUARD GROUP INC, with 9.6862% or 11.06 million shares worth $211.39 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
